Hepatitis C virus – drug resistance genotyping
| Molecular detection of drug resistance in Hepatitis C virus | |
| Microbiology | |
| Virology | |
| ○ Plasma ○ Serum |
Other Information
○ Resistance genotyping in Hepatitis C is intended for patients who have failed a prior HCV therapy containing an NS3, NS5A and/or NS5B inhibitor.
○ Patient samples with viral loads <103 IU/mL are not accepted.
○ Patient samples with viral loads <103 IU/mL are not accepted.
○ Serum: serum separator tube (clotted blood)
○ Plasma: EDTA-blood tube (lavender top)
○ Plasma: EDTA-blood tube (lavender top)
○ Decontaminate skin with 70% alcohol followed by iodine or chlorhexidine, collect at least 5 mL of blood
Refer to section Sample Processing / Delivery
PHOL
○ 28 days
416-586-4800 extension 4432
YES
○ Label specimen container. Place specimens in biohazard bag and seal.
○ Specimens should be stored and transported to the UHN/SH Microbiology Laboratory at refrigeration temperature (2-8˚C) immediately after collection
○ UHN/SH Microbiology Laboratory will refer the original positive specimen to the National Microbiology Laboratory for testing upon request.
○ Specimens should be stored and transported to the UHN/SH Microbiology Laboratory at refrigeration temperature (2-8˚C) immediately after collection
○ UHN/SH Microbiology Laboratory will refer the original positive specimen to the National Microbiology Laboratory for testing upon request.